Goserelin EP Impurity E

• Description :

  Goserelin EP Impurity E is the impurity of Goserelin (HY-13673) [1].

• CAS Number :

  [147688-42-4]

• UNSPSC :

  12352209

• Hazard Statement :

  H302-H315-H319-H335

• Target :

  Drug Derivative

• Type :

  Peptides

• Related Pathways :

  Others

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/goserelin-ep-impurity-e.html

• Solubility :

  H2O

• Smiles :

  O=C([C@H]1NC(CC1)=O)N[C@@H](CC2=CN=CN2)C(N[C@H](C(N[C@@H](CO)C(N[C@H](C(N[C@H](COC(C)(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(N3[C@@H](CCC3)C(NN)=O)=O)=O)=O)=O)CC4=CC=C(C=C4)O)=O)=O)CC5=CNC6=CC=CC=C56)=O

• Molecular Formula :

  C58H83N17O13

• Molecular Weight :

  1226.39

• Precautions :

  P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

• References & Citations :

  [1]Kripa S. Srivastava, et al. Solid phase peptide synthesis process for the production of goserelin. Patent WO2010141276A1.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Peptides

• Clinical Information :

  No Development Reported